Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
48-Hour Action Plan: Patient Safety First, Managed Transparency Second Core Decision (Stated Up Front) We report to regulators immediately—voluntarily—and we disclose on the earnings call. The math is brutal and clear: ~500 patients could develop liver failure over 5 years at current prescribing rates (4M ÷ 8,000).Read the full answer
This is a critical governance and safety scenario. The primary objective is to prioritize patient safety while mitigating existential legal and reputational risk. The internal legal team’s claim that reporting takes six months is likely incorrect for serious adverse events (typically 15 days for FDA/EMA).Read the full answer